These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36230639)

  • 1. Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.
    Vicente R; Alpuim Costa D; Vitorino M; Mendes AD; Santos C; Fontes-Sousa M
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry.
    Peixoto A; Santos C; Pinto P; Pinheiro M; Rocha P; Pinto C; Bizarro S; Veiga I; Principe AS; Maia S; Castro F; Couto R; Gouveia A; Teixeira MR
    Clin Genet; 2015 Jul; 88(1):41-8. PubMed ID: 24916970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
    Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
    BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
    Ewald IP; Cossio SL; Palmero EI; Pinheiro M; Nascimento IL; Machado TM; Sandes KA; Toralles B; Garicochea B; Izetti P; Pereira ML; Bock H; Vargas FR; Moreira MÂ; Peixoto A; Teixeira MR; Ashton-Prolla P
    Genet Mol Biol; 2016; 39(2):223-31. PubMed ID: 27303907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
    Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
    Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Testing for Somatic and Germline
    Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
    Front Oncol; 2020; 10():1318. PubMed ID: 32850417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.
    Peixoto A; Santos C; Pinheiro M; Pinto P; Soares MJ; Rocha P; Gusmão L; Amorim A; van der Hout A; Gerdes AM; Thomassen M; Kruse TA; Cruger D; Sunde L; Bignon YJ; Uhrhammer N; Cornil L; Rouleau E; Lidereau R; Yannoukakos D; Pertesi M; Narod S; Royer R; Costa MM; Lazaro C; Feliubadaló L; Graña B; Blanco I; de la Hoya M; Caldés T; Maillet P; Benais-Pont G; Pardo B; Laitman Y; Friedman E; Velasco EA; Durán M; Miramar MD; Valle AR; Calvo MT; Vega A; Blanco A; Diez O; Gutiérrez-Enríquez S; Balmaña J; Ramon y Cajal T; Alonso C; Baiget M; Foulkes W; Tischkowitz M; Kyle R; Sabbaghian N; Ashton-Prolla P; Ewald IP; Rajkumar T; Mota-Vieira L; Giannini G; Gulino A; Achatz MI; Carraro DM; de Paillerets BB; Remenieras A; Benson C; Casadei S; King MC; Teugels E; Teixeira MR
    Breast Cancer Res Treat; 2011 Jun; 127(3):671-9. PubMed ID: 20652400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.
    Peixoto A; Salgueiro N; Santos C; Varzim G; Rocha P; Soares MJ; Pereira D; Rodrigues H; Bento MJ; Fráguas A; Moura G; Regateiro F; Castedo S; Teixeira MR
    Fam Cancer; 2006; 5(4):379-87. PubMed ID: 16826315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
    Verhoog LC; van den Ouweland AM; Berns E; van Veghel-Plandsoen MM; van Staveren IL; Wagner A; Bartels CC; Tilanus-Linthorst MM; Devilee P; Seynaeve C; Halley DJ; Niermeijer MF; Klijn JG; Meijers-Heijboer H
    Eur J Cancer; 2001 Nov; 37(16):2082-90. PubMed ID: 11597388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of pathogenic non-founder germline mutations in
    Maksimenko J; Irmejs A; Trofimovičs G; Bērziņa D; Skuja E; Purkalne G; Miklaševičs E; Gardovskis J
    Hered Cancer Clin Pract; 2018; 16():12. PubMed ID: 29928469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.
    Rosado-Jiménez L; Mestre-Terkemani Y; García-Aliaga Á; Marín-Vera M; Macías-Cerrolaza JA; Sarabia-Meseguer MD; García-Hernández MR; Zafra-Poves M; Sánchez-Henarejos P; Ayala de la Peña F; Alonso-Romero JL; Noguera-Velasco JA; Ruiz-Espejo F
    Adv Lab Med; 2023 Sep; 4(3):279-287. PubMed ID: 38075165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
    Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
    Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
    Mehemmai C; Cherbal F; Hamdi Y; Guedioura A; Benbrahim W; Bakour R; Abdelhak S
    Pathol Oncol Res; 2020 Apr; 26(2):715-726. PubMed ID: 30715675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary breast cancer and ancestry in the Madeira archipelago: an exploratory study.
    Miguel I; Rodrigues F; Fragoso S; Freixo J; Clara A; Luís A; Bento S; Fernandes M; Bacelar F; Câmara S; Parreira J; Duarte T; Rodrigues P; Santos S; Vaz F
    Ecancermedicalscience; 2021; 15():1261. PubMed ID: 34567246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].
    Duan RR; Sun LX; Zhao HW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.